Phaseline

Targets › LF

LF (Lactotransferrin): drug programs, companies and trials

1 program from 1 company in 1 trial: 1 Phase 2; Other; next expected readout Dec 2026.

Transferrins are iron binding transport proteins which can bind two Fe(3+) ions in association with the binding of an anion, usually bicarbonate..; FUNCTION: [Lactotransferrin]: Major iron-binding and multifunctional protein found in exocrine fluids such as breast milk and mucosal secretions. Has antimicrobial activity, which depends on the extracellular cation concentration. (UniProt, P02788)

Open in Phaseline: the race on LF, likelihood bands and readouts

Programs

CompanyDrugTargetsHighest phaseConditionsNext expected readout
Future University in Egypt4% bovine lactoferrin nanohydrogel
Lactoferrin-based nanohydrogel promoting tissue healing and implant osseointegration
LFPhase 2Dental ImplantDec 2026

Conditions

Dental Implant (1)

Modalities

small molecule (1)

Companies

Future University in Egypt (1)

Related targets

–

Programs group each company's trials by drug; targets and mechanisms come from Open Targets and ChEMBL via Open Targets; expected readouts are Phaseline's estimate from the registry's primary completion date. Facts from the registries only; the approval likelihood is in the app.